Clinical veterinarian's perspective of non-human primate (NHP) use in drug safety studies

被引:0
|
作者
Taylor, Katrina [1 ]
机构
[1] Bristol Myers Squibb Res & Dev, Vet Sci, Syracuse, NY USA
关键词
MACACA-FASCICULARIS; CYNOMOLGUS MONKEYS; ANTIBIOTICS; MACAQUES; MICE; CIPROFLOXACIN; MAURITIUS; RESPONSES; CELLS; MODEL;
D O I
10.3109/15476910903213539
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Owing to their size, cost, and availability, the cynomolgus macaque (Macaca fascicularis) has surpassed the rhesus macaque in its use as a non-human primate preclinical model for drug safety studies. There are three major regions where cynomolgus macaques are bred: China, Southeast Asia, and the island of Mauritius. Country of origin of the macaque is important, as disease status and background disease incidence in non-human primates from each of these sites can differ. Once a source of macaque has been decided, careful monitoring of the animal during breeding and by the importing vendor while the animals are in quarantine is important. During vendor quarantine, the animals should be monitored and evaluated for disease, response to tuberculosis testing, retroviral status, and both ecto- and endoparasites. After animals arrive at the test facility, additional quarantine and acclimation are important to ascertain health status further and to reduce stress on the animals, thereby providing a better research model. The type of caging, food, water, and enrichment should be carefully selected to best suit the needs of the study while working within Federal Regulations (i.e., Animal Welfare Act and Good Laboratory Practices). Careful prescreening by performing tests (such as physical, neurologic, and ophthalmologic examinations), complete blood count, biochemical profile, urinanalysis, electrocardiograms, and pulse oximetry is important when selecting the most appropriate animals for the study. After the in-life portion of the study begins, animals that present with clinical signs should be examined and an appropriate treatment course begun while maintaining study objectives. As many commonly used medications have immunomodulatory effects, having an understanding of the mechanism of action of test articles will aid in the appropriate choice of treatment of study animals. A tiered approach to the treatment of these animals is a conservative and usually acceptable approach.</.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 50 条
  • [31] Non-Human Primate (NHP) Husbandry and Impact on NHP Health: Outcomes from an IQ DruSafe/3RS Industrial Benchmark Survey
    Salian-Mehta, S.
    Poling, J.
    Birkebak, J.
    Rensing, S.
    Carosino, C.
    Santos, R.
    West, W.
    Adams, K.
    Klein, H.
    Fillman-Holliday, D.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2022, 41 (01) : 72 - 73
  • [32] The amygdala and autism: implications from non-human primate studies
    Amaral, DG
    Bauman, MD
    Schumann, CM
    GENES BRAIN AND BEHAVIOR, 2003, 2 (05) : 295 - 302
  • [33] Non-human primate models for immunological studies of HIV eradication
    Silvestri, Guido
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 : 64 - 64
  • [35] NON-HUMAN PRIMATE LEARNING - THE IMPORTANCE OF LEARNING FROM AN EVOLUTIONARY PERSPECTIVE
    POIRIER, FE
    HUSSEY, LK
    ANTHROPOLOGY & EDUCATION QUARTERLY, 1982, 13 (02) : 133 - 148
  • [36] Safety & Efficacy of Fetal Gene Therapy: A Non-Human Primate Model
    Mattar, Citra
    Biswas, Arijit
    Johana, Nuryanti
    Tan, Yvonne
    Tan, Lay Geok
    Bakkour, Sonia
    Choolani, Mahesh
    Chan, Jerry
    MOLECULAR THERAPY, 2017, 25 (05) : 89 - 90
  • [37] Investigating tolerability of subretinally delivered dual AAV-MYO7A vectors in non-human primate (NHP)
    Calabro, Kaitlyn
    Boye, Sanford L.
    Mccullough, Kevin
    Fajardo, Diego
    Smith, W. Clay
    Strang, Christianne E.
    Witherspoon, Douglas C.
    Chakraborty, Dibyendu
    Gamlin, Paul D.
    Boye, Shannon Elizabeth
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [38] The tilt test in non-human primate (NHP) using manual restraint: An improved method to investigate orthostatic hypotension
    Betat, Anne-Marie
    Delpy, Eric
    Bureau, Marie
    Veillard, Jeremie
    La Rochelle, Christophe Drieu
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 366 - 366
  • [39] NON-HUMAN PRIMATE (NHP) OPTIC NERVE HEAD (ONH) PROTEOMIC CHANGE IN EARLY EXPERIMENTAL GLAUCOMA (EEG)
    Burgoyne, Claude
    Stowell, Cheri
    Jang, Geeng-Fu
    Zhang, Lei
    Willard, Belinda
    Crabb, Jack S.
    Crabb, John W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [40] Non-human primate models in drug addiction deserve more attention
    Jian-Hong WANG
    Zoological Research, 2014, 35 (03) : 172 - 173